09/14/2012 - 10:30am

Two generic drug makers have settled with a subsidiary of Johnson & Johnson and another company concerning a drug used to treat attention deficit hyperactivity disorder.

09/14/2012 - 9:57am

The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.

09/13/2012 - 1:03pm

The Food and Drug Administration has approved a generic psychiatric drug made by Lupin Pharmaceuticals, Lupin said Thursday.

09/13/2012 - 9:51am

The Food and Drug Administration has approved a new drug for multiple sclerosis.

09/13/2012 - 8:48am

The National Retail Federation told a congressional panel Wednesday that the Departments of Health and Human Services, Labor and Treasury have used too much informal guidance and not enough formal rule-making in developing regulations to implement the new healthcare reform law, complicating retailers' and other employers' ability to plan for what will be required in 2014.

09/12/2012 - 11:23am

Some common patient complaints regarding mail-order pharmacies and their captive consumers’ lack of choice to switch to another pharmacy if they encounter poor service are highlighted in a new video released Wednesday by the National Community Pharmacists Association.

09/12/2012 - 10:13am

Drug maker Shire is seeking Food and Drug Administration approval for a new usage for a drug used to treat attention deficit hyperactivity disorder, the company said Wednesday.

09/11/2012 - 1:03pm

The Food and Drug Administration on Thursday issued warning letters to PruTect Rx, of Highlands Ranch, Colo., and Trinity Sports Group, of Plano, Texas, for promoting products labeled as dietary supplements with claims to treat concussions and prevent or treat post-concussion syndrome and other neurological disorders.

09/11/2012 - 12:52pm

Louisiana pharmacist Randy Mire testified before Congress Tuesday that efforts to combat the diabetes epidemic in his home state and elsewhere would be significantly undermined if independent community pharmacies like his are forced to stop offering diabetes testing supplies as a result of Medicare’s competitive bidding program for durable medical equipment, according to a National Community Pharmacists Association release.